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Introduction
Tourette syndrome is a common neurobehavioral disorder,
characterized by motor and phonic tics and various behav-
ioral problems including attention deficit hyperactivity
disorder (ADHD) and obsessive-compulsive disorder
(OCD) [1].
There is a long list of diseases causing tics and Tourettism.
Huntington’s disease and neuroacanthocytosis are among the
most important neurodegenerative etiologies [1]. There are
few case reports of neurodegeneration with brain iron accu-
mulation (NBIA) due to presumed or genetically confirmed
pantothenate kinase-associated neurodegeneration (PKAN)
presenting with tics and Tourettism [2–6].
PKAN is an autosomal recessive neurodegenerative dis-
order caused by mutations in the PANK2 gene [7]. The
gene encodes an enzyme named pantothenate kinase 2 that
is activated in the mitochondria and plays an important role
in the coenzyme A (CoA) biosynthesis which is essential
for production of cellular energy and lipid metabolism.
Affected individuals manifest an abnormal iron accumula-
tion in globus pallidus and the substantia nigra that leads to
Beye-of-the-tiger^ sign on magnetic resonance imaging
(MRI) [7].
Herein, we report a case of genetically proven PKAN with
Tourettism as the main clinical feature.
Case
A 13-year-old boy came to our attention due to severe
motor tics. His parents were first cousins and he was the
only child. According to his mother, he had a normal de-
livery and normal motor milestones but he had stuttering
and ADHD since early childhood. Family history for tics,
OCD, and other movement disorders was negative but his
mother had history of ADHD. He was receiving methyl-
phenidate for ADHD when motor tics began at the age 10.
He also developed obsessive and compulsive behavior at
age 12. Rarely, he uttered inappropriate words (coprolalia)
without other phonic tics. He had complex motor tics such
as touching and rubbing objects surrounding him. There
was no history of seizures.
At the time of his first assessment, he was taking risper-
idone for the tics. On examination, his speech was normal.
He had complex motor tics (rubbing the eyes and touching
face and head, neck flexion and extension) (Video 1). On
walking, there was mild dystonic posture of the toes, more
severe on the right side (Video 2). The remainder of his
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neurologic examination was normal. Brain MRI revealed
typical eye of the tiger sign (Fig. 1).
Although the clinical features were not typical of
PKAN, the MRI findings encouraged us for PANK2 mu-
tation screening. The seven exons of PANK 2 were ampli-
fied by polymerase chain reaction (PCR) and sequenced
using ABI Big Dye terminator chemistry (Applied
Biosystems, Foster City, CA). A homozygous missense
mutation, c.G833T, p.Arg278Leu, was detected in the
PANK2 gene. The damaging effect of the observed varia-
tion on the encoded protein was predicted using nine dif-
ferent software packages (Supplementary Table 1 and
Supplementary Fig. 1).
Discussion
NBIAs comprise a rare group of neurologic disorders de-
termined by iron accumulation in the basal ganglia.
PKAN is the most common form of NBIA diseases
causes by mutations in PANK2 gene. This has not been
cleared how mutations in PANK2 result in abnormal iron
accumulation in the basal ganglia and specific features of
the disease. It has been suggested PANK2 mutant protein
fails to fold properly and exhibits no enzymatic activity
that leads to a lack of CoA biosynthesis and subsequent-
ly, an accumulation of free cysteine. This cysteine can
chelate iron. Iron is highly reactive and may produce
reactive oxygen species (ROS) that are destructive for
lipid metabolism and may results in ROS-derived dam-
age, impaired energy production and cell death especially
in basal ganglia that naturally contains high iron content
[7].
The clinical features of PKAN are diverse and exten-
sive depending on whether it begins early (typical form)
or later (atypical form) in life [7]. Among these variegated
clinical features, tics and Tourettism have rarely been re-
ported: to the best of our knowledge, there are only eight
cases of PKAN and tics (Table 1) [2–6]. All of them were
atypical forms of PKAN. Six patients were male and two
were female. Six out of the eight were genetically con-
firmed with mutations in the PANK2 gene different from
the one we detected in our case; the other two patients
were diagnosed clinically. All patients had eye of the tiger
sign on brain MRI. Seven patients had both motor and
phonic tics, one had only motor tics. In three patients, tics
were the first presentation of the disease. Six patients had
OCD and one had ADHD in addition to tics. All cases
developed other movement disorders at presentation or
during the disease course, the most prominent being
dystonia.
Our case is unique since tics were the most prominent
symptom and were accompanied by OCD and ADHD, as
reported in only one previous case [2].
Among the other NBIA syndromes, we found one case
report of neuroferritinopathy with facial tics/stereotypies.
The patient was a 49-year-old man with a 2-year history of
facial tics and vocalizations which were responsive to
tetrabenazine [8].
We should acknowledge here that Tourette syndrome is
a common movement disorder so it is possible that this
case simply represents the coincidental association of a
rare disease (PKAN) with a far more common disease
(Tourette syndrome). On the other hand, studies show neu-
ronal dysfunction in globus pallidus as a unit of cortico-
striato-pallido-thalamic loop in patients with Tourette syn-
drome [9]. Thus, pathological changes in the globus
pallidus of PKAN patients could readily explain the occur-
rence of tics and Tourettism in these patients.
In conclusion, cases mimicking, but not perfectly alike,
a neurodevelopmental disorder, should be investigated fur-
ther, and other possible underlying conditions such as
Fig. 1 Axial brain MRI showing
a typical eye of the tiger on T2
and FLAIR sequences (a and b
respectively)
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PKAN have to be taken into account, before an incorrect
diagnosis is drawn.
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